(Q43949454)

28 November 2017

1 reference

title

Severe rhabdomyolysis and cerivastatin-gemfibrozil combination therapy (English)

1 reference

28 November 2017

0 references

1 reference

Bernardino Roca

1

1 reference

28 November 2017

Begoña Calvo

series ordinal

2

1 reference

28 November 2017

Rafael Monferrer

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Annals of Pharmacotherapy

28 November 2017

1 reference

28 November 2017

36

1 reference

28 November 2017

730-731

1 reference

28 November 2017

4

1 reference

Cerivastatin and gemfibrozil-associated rhabdomyolysis

28 November 2017

1 reference

Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy

21 January 2018

1 reference

Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia

21 January 2018

1 reference

Rhabdomyolysis complicated with acute renal insufficiency in a patient treated with gemfibrozil and cerivastatin

21 January 2018

1 reference

Acute rhabdomyolysis associated with cerivastatin therapy

21 January 2018

1 reference

Severe rhabdomyolysis associated with cerivastatin and gemfibrozil

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A383

1 reference

28 November 2017

1 reference